The End of the Beginning: Cancer, Immunity, and the Future of a Cure

Backorder (temporarily out of stock)

Product Details

$27.95  $25.99
Pegasus Books
Publish Date
6.0 X 8.9 X 1.3 inches | 0.95 pounds

Earn by promoting books

Earn money by sharing your favorite books through our Affiliate program.

Become an affiliate

About the Author

Michael Kinch is a professor at Washington University in St. Louis. He is the author of Between Hope and Fear (Pegasus Books), The End of the Beginning (Pegasus Books) and A Prescription for Change (UNC Press). Beyond his current work documenting the sources of innovation responsible for new medicines, he has led cancer research activities at the biotechnology company MedImmune and the development of medicines to prevent pandemic virus outbreaks at Functional Genetics, Inc. He led drug discovery at Yale University before moving to St Louis.


A richly detailed, expert description of the history of cancer, its treatment, and research that is now producing quantum-leap breakthrough therapy. As the title suggests, scientists have reached only the end of the beginning, but the beginning of the end of cancer is on the horizon, and Kinch's intensely researched, definitely not dumbed down and lucid account makes this superbly clear.
Asking what is meant by the 'deceiving' word 'cancer, ' [the author] provides a nuanced answer that debunks misconceptions. Kinch also describes and explains the pioneering research linking cancer and viruses conducted worldwide during the last century. Readers may will gain from his thoughtful book an improved understanding of the 'promises and perils' involved in finding a cure for cancer.